Cirrus Logic Set to Join the S&P MidCap 400; Amphastar Pharmaceuticals to Join S&P SmallCap 600

Go back to Cirrus Logic Set to Join the S&P MidCap 400; Amphastar Pharmaceuticals to Join S&P SmallCap 600

Canaccord Genuity Raises Price Target on Cirrus Logic, Inc. (CRUS) After Traveling with Management

September 20, 2016 11:32 AM EDT

Canaccord Genuity reiterated a Buy rating on Cirrus Logic, Inc. (NASDAQ: CRUS), and raised the price target to $65.00 (from $56.00), after spending time with management. Some investors are concerned that the increased content in the recently-launched iPhone 7 could mark peak earnings growth for CRUS. However, Canaccord believes that its positive thesis is very much intact.

Analyst Matthew Ramsay commented, "We spent a very productive... More

Jefferies Raises Price Target on ON Semiconductor (ON) Following Acquisition Completion

September 20, 2016 8:01 AM EDT

Jefferies reiterated a Hold rating on ON Semiconductor (NASDAQ: ON), and raised the price target to $13.00 (from $10.50), following the company's announcement that it has completed its acquisition of FCS for $2.4b in cash. Management expects the acquisition to be $0.20 accretive in 2017. In 2018/2019, management expects... More

Jefferies Raises Price Target on ON Semiconductor (ON) Following Acquisition Completion

September 20, 2016 8:00 AM EDT

Jefferies reiterated a Hold rating on ON Semiconductor (NASDAQ: ON), and raised the price target to $13.00 (from $10.50), following the company's announcement that it has completed its acquisition of FCS for $2.4b in cash. Management expects the acquisition to be $0.20 accretive in 2017. In 2018/2019, management expects... More